US Stock MarketDetailed Quotes

CCCC C4 Therapeutics

Watchlist
  • 4.080
  • -0.060-1.45%
Close Jun 18 16:00 ET
  • 4.098
  • +0.018+0.45%
Post 19:59 ET
280.73MMarket Cap-1721P/E (TTM)

C4 Therapeutics Key Stats

C4 Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

3.04M

-19.15%
EPS(YoY)

-0.41

+42.25%

Buy

Jun 4, 2024

C4 Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 7.480M--
--2024/Q2-- / 4.783M--
--2024/Q13.039M / 9.283M--
--2023/Q43.261M / 3.213M--
--2023/Q311.072M / 5.460M--
--2023/Q22.664M / 6.439M--
--2023/Q13.759M / 5.463M--
--2022/Q42.854M / 10.943M--
--2022/Q36.754M / 9.262M--
--2022/Q213.834M / 8.507M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 7.480M--
--2024/Q2-- / 4.783M--
--2024/Q13.039M / 9.283M--
--2023/Q43.261M / 3.213M--
--2023/Q311.072M / 5.460M--
--2023/Q22.664M / 6.439M--
--2023/Q13.759M / 5.463M--
--2022/Q42.854M / 10.943M--
--2022/Q36.754M / 9.262M--
--2022/Q213.834M / 8.507M--

Unlock Free Earnings Estimates

C4 Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Jun 4, 2024

Buy

  • Buy

    50.00%
  • Hold

    50.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg